21:20 , Dec 14, 2018 |  BC Week In Review  |  Financial News

Allen Insitute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of immune-related diseases, paving the way for new diagnostics and therapies. The Allen Institute for Immunology launched on Dec. 12 with...
00:23 , Dec 13, 2018 |  BC Extra  |  Preclinical News

Allen Institute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of immune-related diseases, paving the way for new diagnostics and therapies. The Allen Institute for Immunology launched Wednesday with $125 million...
22:30 , Jun 8, 2017 |  BC Innovations  |  Finance

The bio-tech bridge

Last year’s flurry of interest from tech titans has brought a wealth of new funding to translational science that is gaining them status as new and important players in the biotech ecosystem. With a heavy...
01:05 , Apr 21, 2017 |  BC Innovations  |  Product R&D

Making marks at AACR

Biomarkers that could stratify patients, point to treatment combinations or predict toxicity were a major part of the conversation at this year’s AACR conference, where they emerged as potential difference makers for a range of...
00:37 , May 13, 2016 |  BC Extra  |  Clinical News

Studies link Zika directly to microcephaly, identify target

Researchers have shown the first experimental evidence linking Zika virus infection directly with microcephaly in brain organoids and mice, and have identified toll-like receptor 3 ( TLR3 ) as the first molecular target to treat...
07:00 , Apr 14, 2016 |  BC Innovations  |  Translation in Brief

Better half

A group of U.S. and Israeli researchers has developed a method to turn unfertilized human eggs into dividing embryonic stem cells (ESCs) containing only half the normal number of chromosomes. The haploid cells could both...
07:00 , Jun 24, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer Cysteine protease In vitro studies suggest that a yeast-derived cysteine protease inhibitor could help treat or prevent cancer metastases. Bioassays of Streptomyces spp....
08:00 , Feb 19, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Infectious disease Leishmaniasis CD40; IL-10; IL-12 In vitro and mouse studies suggest that boosting membrane cholesterol concentrations in macrophages could help...
08:00 , Mar 5, 2007 |  BioCentury  |  Product Development

Beyond 'me better'

Osteoporosis represents one of the paradoxes of modern drug development, where a huge market and the success of current treatments provides few incentives for novel approaches, even though the relatively small number of therapeutic alternatives...
08:00 , Nov 21, 2005 |  BioCentury  |  Politics, Policy & Law

Stem cell blowback

A year after California voters enacted Proposition 71, an initiative that committed the state to raise and disburse $3 billion for embryonic stem cell science over a decade, the state hasn't spent a penny on...